4-Chloro-[1,2,4]triazolo[4,3-a]quinoxaline

Catalog No.: 
ACUOPA152
CAS No.: 
62603-54-7
Molecular Formula: 
C9H5ClN4
Molecular Weight: 
204.62
4-Chloro-[1,2,4]triazolo[4,3-a]quinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$90.00In stockInquiry
250mg95%$153.00In stockInquiry
1g95%$394.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-[1,2,4]triazolo[4,3-a]quinoxaline
IUPAC Name4-chloro-[1,2,4]triazolo[4,3-a]quinoxaline
MDL No.MFCD00140798
Molecular FormulaC9H5ClN4
Molecular Weight204.62
SMILESClC1=NC2=C(N3C1=NN=C3)C=CC=C2
InChI KeyNLAAGSHTVZHFTR-UHFFFAOYSA-N
Synonym4-CHLORO[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE;[1,2,4]Triazolo[4,3-a]quinoxaline, 4-chloro-;-CHLORO[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE
CAS No.62603-54-7
PubChem CID1126118

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUOPA152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYINH463 route compound structure diagram
    ACYINH46351347-93-4In Stock
  4. Then
  5. ACUOPA152 route product structure diagram
    ACUOPA15262603-54-7In Stock
Inquiry

2. ACUOPA152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUOPA152 route product structure diagram
    ACUOPA15262603-54-7In Stock
Inquiry

3. ACUOPA152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUOPA152 route product structure diagram
    ACUOPA15262603-54-7In Stock
Inquiry

Comments (0)